Quick Answer
INTERPACE BIOSCIENCES, INC. reported Long-Term Debt of $7.91 million for fiscal year 2016.
INTERPACE BIOSCIENCES, INC. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2016 | $7.91M | +9.3% |
| 2015 | $7.23M | -73.4% |
| 2014 | $27.15M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| March 31, 2017 | $4.36M | -28.9% | -44.8% |
| December 31, 2016 | $7.91M | +9.3% | +50.1% |
| September 30, 2016 | $5.27M | -81.1% | +4.2% |
| June 30, 2016 | $5.05M | -81.7% | -17.6% |
| March 31, 2016 | $6.14M | -77.6% | -15.2% |
| December 31, 2015 | $7.23M | -73.4% | -74.1% |
| September 30, 2015 | $27.91M | — | +0.8% |
| June 30, 2015 | $27.69M | — | +1.3% |
- INTERPACE BIOSCIENCES, INC. showed an increase of +9.3% in Long-Term Debt compared to the prior fiscal year.
- Over the 2014–2016 period, INTERPACE BIOSCIENCES, INC.’s long-term debt has declined by 70.9% (from $27.15 million to $7.91 million).
- The most recent figure is from INTERPACE BIOSCIENCES, INC.’s fiscal year 2017 report (Form 10-K), filed with the SEC on March 23, 2018.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: